BRISTOL-MYERS SQUIBB COMPANY Lessee, Operating Lease, Liability, to be Paid, Year One
BRISTOL-MYERS SQUIBB COMPANY (BMY) had Lessee, Operating Lease, Liability, to be Paid, Year One of $271.00 million as of 2025-12-31, per its 10-K filed 2026-02-11.
Financial Statements › Notes › Commitment and Contingencies › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2026-02-11
- 2025-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $271.00M.
- 2024-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $255.00M.
- 2023-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $225.00M.
- 2022-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $187.00M.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year One |
|---|---|
| 2025-12-31 | $271.00M 10-K · filed 2026-02-11 |
| 2024-12-31 | $255.00M 10-K · filed 2025-02-12 |
| 2023-12-31 | $225.00M 10-K · filed 2024-02-13 |
| 2022-12-31 | $187.00M 10-K · filed 2023-02-14 |
| 2021-12-31 | $190.00M 10-K · filed 2022-02-09 |
| 2020-12-31 | $195.00M 10-K · filed 2021-02-10 |
| 2019-12-31 | $165.00M 10-K · filed 2020-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |